Contrafect Obtains $9,997,650 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bd0cc3d6-9dac-4756-9003-e5832ebf95f5&Preview=1 - Date
7/4/2013 - Company Name
Contrafect - Mailing Address
28 Wells Avenue 3rd Floor Yonkers, NY 10701 - Company Description
ContraFect is a biotechnology company pioneering the use of monoclonal antibodies to treat life-threatening infectious diseases. - Website
http://www.contrafect.com - Transaction Type
Venture Equity - Transaction Amount
$9,997,650 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
